FONAR Co. (NASDAQ:FONR – Get Free Report) was the target of a significant growth in short interest in December. As of December 31st, there was short interest totalling 17,100 shares, a growth of 6.2% from the December 15th total of 16,100 shares. Approximately 0.3% of the shares of the stock are sold short. Based on an average trading volume of 16,600 shares, the short-interest ratio is currently 1.0 days.
Wall Street Analysts Forecast Growth
Separately, StockNews.com downgraded FONAR from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 16th.
View Our Latest Research Report on FONAR
Institutional Trading of FONAR
FONAR Stock Down 0.4 %
FONAR stock traded down $0.06 during midday trading on Friday, hitting $15.22. The company’s stock had a trading volume of 17,352 shares, compared to its average volume of 9,350. FONAR has a 12 month low of $14.05 and a 12 month high of $24.05. The stock’s 50-day moving average price is $15.48 and its 200-day moving average price is $16.23. The company has a market capitalization of $96.31 million, a PE ratio of 10.87 and a beta of 1.22.
FONAR Company Profile
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
Featured Articles
- Five stocks we like better than FONAR
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Oilfield Leader SLB: An AI Name You Need to Know
- 3 Dividend Kings To Consider
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for FONAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FONAR and related companies with MarketBeat.com's FREE daily email newsletter.